- Global Pharma News & Resources

Press Releases - 2019-10-03

Date Title Company
03-Oct-2019 Rafael Holdings Reports Fourth Quarter and Full Fiscal Year 2019 Results Rafael Holdings, Inc.
03-Oct-2019 Prometheus Biosciences, Inc., Enters Into Multi-Target Strategic Collaboration with Takeda to Develop Targeted Therapies for Inflammatory Bowel Disease Prometheus Biosciences, Inc.
03-Oct-2019 Acurx's Novel Lead Antibiotic Candidate Presented at Two Prominent International Scientific Conferences Acurx Pharmaceuticals, LLC
03-Oct-2019 FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic U.S. Food and Drug Administration
03-Oct-2019 Bavarian Nordic Completes Enrollment of Phase 2 Trial in Chordoma Patients Bavarian Nordic A/S
03-Oct-2019 Biovica will present at the Biomarkers & Precision Medicine Congress in San Diego Biovica
03-Oct-2019 Clinical update and conference presentations ReNeuron Group plc
03-Oct-2019 Teneobio Licenses Oncology Multispecific Product to Janssen Teneobio, Inc
03-Oct-2019 Lilly Announces Positive Results for Verzenios in MONARCH 3 Study in Patients with HR+, HER2- Breast Cancer Eli Lilly and Company Limited
03-Oct-2019 Domain Therapeutics reaches two milestones in multi-target research collaboration with Boehringer Ingelheim Domain Therapeutics
03-Oct-2019 New Class II Biological Safety Cabinet Delivers Superior Performance for Product, Personnel and Environmental Protection Thermo Fisher Scientific
03-Oct-2019 MaxCyte Presents Updates on First-in-class CARMA™ Platform at Upcoming Meetings MaxCyte
03-Oct-2019 Novartis announces positive results from Phase III PALLADIUM study of inhaled combination QMF149 in patients with uncontrolled asthma Novartis
03-Oct-2019 First West Coast CME Program on Tick-borne Disease Provides New Data, Insights from Researchers Bay Area Lyme Foundation
03-Oct-2019 Pierre Fabre and its partner Pfizer present interim analysis results from Phase 3 BEACON CRC trial of encorafenib, binimetinib and cetuximab for the treatment of BRAFV600E-mutant metastatic colorectal cancer Pierre Fabre
03-Oct-2019 Lonza’s MODA-ES™ Platform helps Nephron Pharmaceuticals move from paper to an EBR in nine months – Case study to be presented at 2019 ISPE Annual Meeting Lonza
03-Oct-2019 NMI® at 52.6%; September Non-Manufacturing ISM® Report On Business® Institute for Supply Management
03-Oct-2019 Prime Therapeutics Study Reveals 60% Surge in Number of People Taking Ultra Expensive Medicines Prime Therapeutics LLC
03-Oct-2019 The importance of oral syringes Valley Northern
03-Oct-2019 Iceni Diagnostics CEO appointed Director of world-leading Manchester Institute of Biotechnology Iceni Diagnostics